Cargando…
Correction: Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292628/ https://www.ncbi.nlm.nih.gov/pubmed/30543718 http://dx.doi.org/10.1371/journal.pone.0209522 |
| _version_ | 1783380422237880320 |
|---|---|
| author | Chrobok, Navina L. Bol, John G. J. M. Jongenelen, Cornelis A. Brevé, John J. P. El Alaoui, Said Fidalgo-Lopez, Javier Fournet, Guy Joseph, Benoît Wilhelmus, Micha M. M. Drukarch, Benjamin van Dam, Anne-Marie |
| author_facet | Chrobok, Navina L. Bol, John G. J. M. Jongenelen, Cornelis A. Brevé, John J. P. El Alaoui, Said Fidalgo-Lopez, Javier Fournet, Guy Joseph, Benoît Wilhelmus, Micha M. M. Drukarch, Benjamin van Dam, Anne-Marie |
| author_sort | Chrobok, Navina L. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6292628 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Public Library of Science |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-62926282018-12-28 Correction: Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis Chrobok, Navina L. Bol, John G. J. M. Jongenelen, Cornelis A. Brevé, John J. P. El Alaoui, Said Fidalgo-Lopez, Javier Fournet, Guy Joseph, Benoît Wilhelmus, Micha M. M. Drukarch, Benjamin van Dam, Anne-Marie PLoS One Correction Public Library of Science 2018-12-13 /pmc/articles/PMC6292628/ /pubmed/30543718 http://dx.doi.org/10.1371/journal.pone.0209522 Text en © 2018 Chrobok et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Correction Chrobok, Navina L. Bol, John G. J. M. Jongenelen, Cornelis A. Brevé, John J. P. El Alaoui, Said Fidalgo-Lopez, Javier Fournet, Guy Joseph, Benoît Wilhelmus, Micha M. M. Drukarch, Benjamin van Dam, Anne-Marie Correction: Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis |
| title | Correction: Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis |
| title_full | Correction: Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis |
| title_fullStr | Correction: Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis |
| title_full_unstemmed | Correction: Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis |
| title_short | Correction: Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis |
| title_sort | correction: characterization of transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292628/ https://www.ncbi.nlm.nih.gov/pubmed/30543718 http://dx.doi.org/10.1371/journal.pone.0209522 |
| work_keys_str_mv | AT chroboknavinal correctioncharacterizationoftransglutaminase2activityinhibitorsinmonocytesinvitroandtheireffectinamousemodelformultiplesclerosis AT boljohngjm correctioncharacterizationoftransglutaminase2activityinhibitorsinmonocytesinvitroandtheireffectinamousemodelformultiplesclerosis AT jongenelencornelisa correctioncharacterizationoftransglutaminase2activityinhibitorsinmonocytesinvitroandtheireffectinamousemodelformultiplesclerosis AT brevejohnjp correctioncharacterizationoftransglutaminase2activityinhibitorsinmonocytesinvitroandtheireffectinamousemodelformultiplesclerosis AT elalaouisaid correctioncharacterizationoftransglutaminase2activityinhibitorsinmonocytesinvitroandtheireffectinamousemodelformultiplesclerosis AT fidalgolopezjavier correctioncharacterizationoftransglutaminase2activityinhibitorsinmonocytesinvitroandtheireffectinamousemodelformultiplesclerosis AT fournetguy correctioncharacterizationoftransglutaminase2activityinhibitorsinmonocytesinvitroandtheireffectinamousemodelformultiplesclerosis AT josephbenoit correctioncharacterizationoftransglutaminase2activityinhibitorsinmonocytesinvitroandtheireffectinamousemodelformultiplesclerosis AT wilhelmusmichamm correctioncharacterizationoftransglutaminase2activityinhibitorsinmonocytesinvitroandtheireffectinamousemodelformultiplesclerosis AT drukarchbenjamin correctioncharacterizationoftransglutaminase2activityinhibitorsinmonocytesinvitroandtheireffectinamousemodelformultiplesclerosis AT vandamannemarie correctioncharacterizationoftransglutaminase2activityinhibitorsinmonocytesinvitroandtheireffectinamousemodelformultiplesclerosis |